title: Bone Regeneration Is Promoted by Orally Administered Bovine Lactoferrin in a Rabbit Tibial Distraction Osteogenesis Model.
abstract: BACKGROUND
  Lactoferrin, an iron-binding glycoprotein which belongs to the transferrin family, has been shown to promote bone growth. However, reports regarding effects of lactoferrin on bone regeneration during distraction osteogenesis are limited. Our study was designed to investigate the effect of bovine lactoferrin treatment on bone formation of the distracted callus.
  
  
  OBJECTIVE
  We asked whether bovine lactoferrin enhances bone formation of the distraction callus as determined by (1) radiographic and histologic appearances; (2) dual-energy x-ray absorptiometry (DXA) analysis of bone mineral composition and bone mineral density; (3) micro-CT measures of trabecular architecture; and (4) biomechanical strength of the healing bone. Additionally, serology, reverse transcription (RT)-PCR, and immunohistochemistry were used to explore the possible mechanisms of bovine lactoferrin use on bone formation during distraction osteogenesis.
  
  
  METHODS
  Unilateral tibial osteodistraction was performed on 80 New Zealand White rabbits with a distraction rate of 1 mm per day for 10 days. Animals then were divided randomly into two groups: (1) vehicle and (2) bovine lactoferrin. At 4 and 8 weeks after completion of distraction, the animals were sacrificed. Lengthened tibias and serum samples were obtained and subjected to radiologic, DXA, micro-CT, histologic, and biomechanical examinations, and serum, RT-PCR and immunohistochemical analyses.
  
  
  RESULTS
  Radiologic, DXA, micro-CT, histologic, and biomechanical examinations indicated that bovine lactoferrin treatment not only accelerated bone formation at early stages of distraction osteogenesis but also promoted bone consolidation at late stages. The ultimate force of the distracted calluses was increased by 37% (118.8 ± 6.65 N in the lactoferrin group and 86.5 ± 5.47 N in the vehicle group; p < 0.001) and 84% (384.8 ± 18.4 N in the lactoferrin group and 209.0 ± 15.2 N in the vehicle group; p < 0.001) at 4 and 8 weeks, respectively. Moreover, serum analysis showed that bovine lactoferrin treatment significantly increased serum levels of bone alkaline phosphatase and decreased serum levels of tartrate resistant acid phosphatase 5b. In addition, RT-PCR and immunohistochemical analyses suggested that bovine lactoferrin treatment induced a lower receptor activator of nuclear factor-kappaB (RANK) ligand/osteoprotegerin (RANKL/OPG) ratio in the distracted callus.
  
  
  CONCLUSIONS
  The results of our study suggest that bovine lactoferrin treatment could promote bone regeneration during distraction osteogenesis in the rabbit. The results indicate that the OPG/RANKL/RANK system might be a major mechanism for increased bone formation and decreased bone resorption in distraction osteogenesis with bovine lactoferrin treatment.
  
  
  CONCLUSIONS
  Oral administration of bovine lactoferrin may provide a feasible approach for promoting osteogenesis during distraction osteogenesis.
authors.affiliation: State Key Laboratory of Oral Diseases and Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, NO. 14, Section 3, Southern Renmin Road, Chengdu, 610041, Sichuan, China.
authors.forename: Wenyang
authors.initials: W
authors.lastname: Li
authors.forename: Songsong
authors.initials: S
authors.lastname: Zhu
authors.forename: Jing
authors.initials: J
authors.lastname: Hu
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001861:Bone Regeneration / Q000187:drug effects*; D002417:Cattle; D007781:Lactoferrin / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D023421:Models, Animal; D019857:Osteogenesis, Distraction; D011817:Rabbits; D013977:Tibia / Q000601:surgery*
chemical_list: D007781:Lactoferrin
references.citation: Clin Orthop Relat Res. 1989 Feb;(239):263-85
references.pmid: 2912628
references.citation: Bone. 2000 Jun;26(6):619-24
references.pmid: 10831934
references.citation: Clin Orthop Relat Res. 1990 Jan;(250):81-104
references.pmid: 2403498
references.citation: Endocrinology. 1999 Apr;140(4):1852-60
references.pmid: 10098524
references.citation: Clin Exp Metastasis. 1999 Feb;17(1):35-40
references.pmid: 10390145
references.citation: Clin Med Res. 2005 May;3(2):93-101
references.pmid: 16012127
references.citation: J Orthop Res. 2006 Feb;24(2):263-70
references.pmid: 16435359
references.citation: J Orthop Res. 2007 Feb;25(2):241-51
references.pmid: 17089407
references.citation: Postepy Hig Med Dosw (Online). 2007;61:129-50
references.pmid: 17410054
references.citation: Am J Gastroenterol. 2008 Jan;103(1):162-9
references.pmid: 17916108
references.citation: Lab Invest. 2010 Aug;90(8):1236-46
references.pmid: 20421871
references.citation: Int J Oral Sci. 2009 Sep;1(3):143-50
references.pmid: 20695079
references.citation: J Orthop Surg (Hong Kong). 2010 Aug;18(2):228-34
references.pmid: 20808018
references.citation: J Orthop Res. 2011 Jul;29(7):1093-8
references.pmid: 21284032
references.citation: Injury. 2011 Aug;42(8):821-4
references.pmid: 21513935
references.citation: FEBS Lett. 2012 Feb 3;586(3):229-34
references.pmid: 22226679
references.citation: Biochim Biophys Acta. 2012 Mar;1820(3):226-36
references.pmid: 21726601
references.citation: Biochem Cell Biol. 2012 Jun;90(3):252-68
references.pmid: 22136726
references.citation: Acta Pharmacol Sin. 2012 Oct;33(10):1277-84
references.pmid: 22902986
references.citation: Br J Plast Surg. 1999 Jul;52(5):343-50
references.pmid: 10618975
references.citation: Bone. 2010 Apr;46(4):1156-61
references.pmid: 20036345
references.citation: J Nutr. 2001 Aug;131(8):2101-4
references.pmid: 11481401
references.citation: J Orthop Res. 2002 Jul;20(4):779-88
references.pmid: 12168667
references.citation: Clin Exp Immunol. 2003 May;132(2):352-9
references.pmid: 12699428
references.citation: J Bone Joint Surg Am. 2003;85-A Suppl 3:124-30
references.pmid: 12925619
references.citation: Clin Orthop Relat Res. 1989 Jan;(238):249-81
references.pmid: 2910611
references.citation: Bone. 2013 Sep;56(1):9-15
references.pmid: 23643680
references.citation: PLoS One. 2013;8(9):e74672
references.pmid: 24040314
references.citation: Biochimie. 2009 Jan;91(1):11-8
references.pmid: 18539153
references.citation: Cell Biol Int. 2009 Mar;33(3):283-9
references.pmid: 19103298
references.citation: J Nutr. 2009 May;139(5):958-64
references.pmid: 19321577
references.citation: Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1281-8
references.pmid: 19336659
references.citation: J Bone Miner Res. 2009 Feb;24(2):196-208
references.pmid: 19016594
references.citation: Osteoporos Int. 2009 Sep;20(9):1603-11
references.pmid: 19172341
references.citation: Clin Orthop Relat Res. 1989 Jun;(243):71-9
references.pmid: 2656035